ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Salofalk 250, Filmtabletten - 100 Tablette(n)
46674022 Dr. Falk Pharma AG
Salofalk 250, Filmtabletten19.12.1984
  19.12.1984
Mesalazine (A07EC02)01.01.2005
WHO-DDD 
04.09.100 Tablette(n)
04.09. 
B  
Yes 
IPCI
23.20No
    
10 %43.10
7680466740226Synthetika
1149974 
Composition
mesalazinum 250 mg, natrii carbonas, glycinum, povidonum K 25, cellulosum microcristallinum, silica colloidalis anhydrica, calcii stearas, hypromellosum, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, macrogolum 6000, talcum, copolymerum methacrylatis butylati basicum, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 47.72 mg.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Mesalazine250 mg
BAG: Active AgentDose
Mesalazine250 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
Acidi Methacrylici Überzug
Calcii Stearas  
Cellulosum Microcristallinum  
Copolymerum Methacrylatis Butylati Basicum  
E 171 color.
E 172 color.
Ethylis Acrylatis Polymerisatum  
Glycin  
Hypromellosum  
Macrogol6000  
Sodium Carbonate  
Povidonum K25  
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 03.02.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home